Skip to content

Objective Evaluation of Ocular Surface Lubricants in Two Environments

Objective Evaluation of Ocular Surface Lubricants

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01375582
Enrollment
20
Registered
2011-06-17
Start date
2011-06-30
Completion date
2012-06-30
Last updated
2022-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye

Keywords

Dry Eye, tear film, lipid, tear volume, environmental chamber, thermal imaging

Brief summary

This study will evaluate ocular surface lubricants in subjects with dry eye syndrome.

Detailed description

This study will objectively evaluate ocular surface lubricants in subjects with dry eye syndrome. Lubricants contain compounds that are purported to improve dry eye symptoms, although objective data is not available. The investigators seek to objectively evaluate the effectiveness of two lubricants and compare the results to a saline eye drop (control). The investigators will assess the lipid layer before and after the administration of three products in the same eye of 25 dry eye subjects using the ellipsometry, imaging in a normal environment. Subsequently the investigators will change the environment to one that causes the subjects' ocular surface to experience evaporative stress (warmer, less humid and greater air flow) and perform the before and after drop administration measurements with the same three products in the same eye as the first environment.

Interventions

DRUGB & L Soothe Lubricant Eye Drops

Eye Drop

DRUGLiposic EDO

Eye Drop

DRUGOcuFresh Eye Wash

Saline drop

Sponsors

Bausch & Lomb Incorporated
CollaboratorINDUSTRY
University of Rochester
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
30 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 30-75 years * Good general health * Willing to spend time for the study; approximately one hour for a screening visit and 90 minutes for each of the measurement visits * Currently using an OTC artificial tear for ocular comfort, at least occasionally. * At least one positive dry eye symptom.

Exclusion criteria

* Current eye disease, infection or inflammation that requires the use of any prescription ocular medication. * Recent past eye surgery. * Female subjects may not be pregnant or lactating. * Infectious diseases

Design outcomes

Primary

MeasureTime frameDescription
Tear Film PropertiesMeasurements: There is no time restriction between the screening and 1st measurement. 6 measurement visits occur approximately 7 days apart but can range from 3 to 14 days. The time between visit 3 and 4 are not be closer than 3 days, but no upper limit.The wavefront sensor instrument measures the eye's ability to create a sharp image. Ellipsometer (E) data identifies changes in lipid thickness and refractive index over the cornea. A thermal (T) imaging system provides thermal maps of the subject's eyes and face adjacent to the eyes. A questionnaire (Q) will ask subjects about their test eye's comfort. Subjects will be asked the questions prior to instillation of the eye drop and after each set of measurements.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026